Search Results - "Smyth, John F"

Refine Results
  1. 1
  2. 2
  3. 3

    WWOX Gene Expression Abolishes Ovarian Cancer Tumorigenicity In vivo and Decreases Attachment to Fibronectin via Integrin α3 by GOURLEY, Charlie, PAIGE, Adam J. W, SMYTH, John F, GABRA, Hani, TAILOR, Karen J, WARD, Carol, KUSKE, Barbara, JIEQING ZHANG, MINGJUN SUN, JANCZAR, Szymon, HARRISON, David J, MUIR, Morwenna

    Published in Cancer research (Chicago, Ill.) (01-06-2009)
    “…Abstract The WW domain–containing oxidoreductase (WWOX) gene is located at FRA16D, a common fragile site involved in human cancer. Targeted deletion of Wwox in…”
    Get full text
    Journal Article
  4. 4

    Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer by MACLEOD, Kenneth, MULLEN, Peter, SEWELL, Jane, RABIASZ, Genevieve, LAWRIE, Sandra, MILLER, Eric, SMYTH, John F, LANGDON, Simon P

    Published in Cancer research (Chicago, Ill.) (01-08-2005)
    “…The majority of ovarian cancer patients are treated with platinum-based chemotherapy, but the emergence of resistance to such chemotherapy severely limits its…”
    Get full text
    Journal Article
  5. 5

    Estrogen receptor-α mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen by O’Donnell, Amanda J M, Macleod, Kenneth G, Burns, David J, Smyth, John F, Langdon, Simon P

    Published in Endocrine-related cancer (01-12-2005)
    “…Estrogens play a significant role in the development, growth, invasion and metastasis of ovarian tumors. The transcriptional program regulated by 17β-estradiol…”
    Get full text
    Journal Article
  6. 6

    Sensitivity to pertuzumab (2C4) in ovarian cancer models: cross-talk with estrogen receptor signaling by Mullen, Peter, Cameron, David A, Hasmann, Max, Smyth, John F, Langdon, Simon P

    Published in Molecular cancer therapeutics (01-01-2007)
    “…Pertuzumab (Omnitarg, rhuMab 2C4) is a humanized monoclonal antibody, which inhibits HER2 dimerization. Because it has shown some clinical activity in ovarian…”
    Get full text
    Journal Article
  7. 7

    Insulin-like Growth Factor Binding Proteins IGFBP3, IGFBP4, and IGFBP5 Predict Endocrine Responsiveness in Patients with Ovarian Cancer by WALKER, Graeme, MACLEOD, Kenneth, WILLIAMS, Alistair R. W, CAMERON, David A, SMYTH, John F, LANGDON, Simon P

    Published in Clinical cancer research (01-03-2007)
    “…Purpose: This study sought to explore the predictive value of the insulin-like growth factor (IGF) binding proteins (IGFBP) as markers of response in ovarian…”
    Get full text
    Journal Article
  8. 8

    OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer by Sellar, Grant C, Gabra, Hani, Watt, Karen P, Rabiasz, Genevieve J, Stronach, Euan A, Li, Li, Miller, Eric P, Massie, Charles E, Miller, Jayne, Contreras-Moreira, Bruno, Scott, Diane, Brown, Iain, Williams, Alastair R, Bates, Paul A, Smyth, John F

    Published in Nature genetics (01-07-2003)
    “…Epithelial ovarian cancer (EOC), the leading cause of death from gynecological malignancy, is a poorly understood disease. The typically advanced presentation…”
    Get full text
    Journal Article
  9. 9

    The IgLON Family in Epithelial Ovarian Cancer: Expression Profiles and Clinicopathologic Correlates by NTOUGKOS, Evangelos, RUSH, Robert, SCOTT, Diane, FRANKENBERG, Tobias, GABRA, Hani, SMYTH, John F, SELLAR, Grant C

    Published in Clinical cancer research (15-08-2005)
    “…Purpose: The IgLON family of cell adhesion molecules, comprising OPCML, HNT, LSAMP, and NEGR1, has recently been linked to cancer, through two of its members…”
    Get full text
    Journal Article
  10. 10

    Phase I Clinical and Pharmacokinetic Study of Plitidepsin as a 1-Hour Weekly Intravenous Infusion in Patients with Advanced Solid Tumors by Miguel A. Izquierdo, Angela Bowman, Margarita García, Duncan Jodrell, Marisa Martinez, Beatriz Pardo, Javier Gómez, José A. López-Martin, José Jimeno, José R. Germá, John F. Smyth

    Published in Clinical cancer research (15-05-2008)
    “…Purpose: Plitidepsin, given as a 1-hour weekly i.v. infusion for 3 consecutive weeks during a 4-week treatment cycle, was investigated in patients with solid…”
    Get full text
    Journal Article
  11. 11

    Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect by Hayward, Richard L, Macpherson, Janet S, Cummings, Jeff, Monia, Brett P, Smyth, John F, Jodrell, Duncan I

    Published in Molecular cancer therapeutics (01-02-2004)
    “…Oxaliplatin, licensed for colorectal cancer chemotherapy, damages DNA by generating intrastrand and interstrand cross-links and can induce apoptosis via a…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Neuregulin Expression, Function, and Signaling in Human Ovarian Cancer Cells by GILMOUR, Lynn M. R, MACLEOD, Kenneth G, MCCAIG, Alison, SEWELL, Jane M, GULLICK, William J, SMYTH, John F, LANGDON, Simon P

    Published in Clinical cancer research (01-12-2002)
    “…Purpose: To investigate the expression and function of neuregulin (NRG) isoforms in ovarian cancer cell lines and tumor samples. Experimental Design:…”
    Get full text
    Journal Article
  14. 14

    Antisense Bcl-xl Down-Regulation Switches the Response to Topoisomerase I Inhibition from Senescence to Apoptosis in Colorectal Cancer Cells, Enhancing Global Cytotoxicity by HAYWARD, Richard L, MACPHERSON, Janet S, CUMMINGS, Jeff, MONIA, Brett P, SMYTH, John F, JODRELL, Duncan I

    Published in Clinical cancer research (01-07-2003)
    “…Purpose: To identify determinants of the effect of antisense-mediated Bcl-xl down-regulation (Bcl-xl knockdown) on the response of colorectal cancer cells to…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Association of galectin-3 expression with melanoma progression and prognosis by Brown, Ewan R, Doig, Tamasin, Anderson, Niall, Brenn, Thomas, Doherty, Val, Xu, Yan, Bartlett, John M.S, Smyth, John F, Melton, David W

    Published in European journal of cancer (1990) (01-04-2012)
    “…Abstract Aims Galectin-3 plays an important role in adhesion, proliferation, differentiation, angiogenesis and metastasis in multiple tumours. To investigate…”
    Get full text
    Journal Article
  17. 17

    Endometrioid Epithelial Ovarian Cancer : 20 Years of Prospectively Collected Data From a Single Center by STOREY, Dawn J, RUSH, Robert, STEWART, Moira, RYE, Tzyvia, AL-NAFUSSI, Awatif, WILLIAMS, Alistair R, SMYTH, John F, GABRA, Hani

    Published in Cancer (15-05-2008)
    “…Clinicopathological features and outcome of women with endometrioid and serous ovarian adenocarcinoma were compared. Between 1984 and 2004, baseline and…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer by Walker, Graeme, MacLeod, Kenneth, Williams, Alistair R.W, Cameron, David A, Smyth, John F, Langdon, Simon P

    Published in Gynecologic oncology (01-09-2007)
    “…Abstract Objective To explore the predictive value of estrogen-regulated gene changes as indicators of sensitivity in ovarian cancer patients treated with the…”
    Get full text
    Journal Article